Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1993-11-1
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0959-8049
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
29A
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
474-5
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:8398350-Antigens, CD4,
pubmed-meshheading:8398350-Carcinoma, Renal Cell,
pubmed-meshheading:8398350-Humans,
pubmed-meshheading:8398350-Interleukin-2,
pubmed-meshheading:8398350-Kidney Neoplasms,
pubmed-meshheading:8398350-Killer Cells, Natural,
pubmed-meshheading:8398350-Leukocyte Count,
pubmed-meshheading:8398350-Lymphocyte Activation
|
| pubmed:year |
1993
|
| pubmed:articleTitle |
Role of interleukin-2 in regulating lymphocyte activation and recirculation.
|
| pubmed:publicationType |
Letter
|